Novo Nordisk Stock Target Price and Analyst Consensus
| NVO Stock | USD 128.64 3.38 2.70% |
The current analyst and expert consensus on Novo Nordisk is Buy, with 1 strong sell and 5 strong buy opinions. The current projected Novo Nordisk target price consensus is 80.40 with 11 analyst opinions. The most common way Novo Nordisk AS analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Novo Nordisk executives and customers to further validate their buy or sell advice. Novo Nordisk buy-or-sell recommendation module provides average expert sentiment on the projected Novo Nordisk AS target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Novo Nordisk to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 73.16 | Highest Forecast 89.24 | Target Price 80.4 |
Novo |
It's important to approach Novo Nordisk's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Novo Nordisk price targets
Novo Nordisk's stock target price is an estimate of its future price, usually made by analysts. Using Novo Nordisk's target price to determine if it is a suitable investment can be done through the following steps:- Look at Novo Nordisk's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Novo Nordisk's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Novo Nordisk Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Novo Nordisk is a key component of Novo Nordisk valuation and have some predictive power on the future returns of a Novo Nordisk.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novo Nordisk's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Momentum Invested over 50 shares | |
 | ESG Investing Invested few shares | |
 | Dividend Beast Invested over 70 shares | |
 | Power Assets Invested over 200 shares | |
 | Driverless Cars Invested over 200 shares | |
Check out Macroaxis Advice on Novo Nordisk to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
The data published in Novo Nordisk's official financial statements usually reflect Novo Nordisk's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Novo Nordisk AS. For example, before you start analyzing numbers published by Novo accountants, it's critical to develop an understanding of what Novo Nordisk's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Novo Nordisk's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novo Nordisk's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Novo Nordisk's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Novo Nordisk AS. Please utilize our Beneish M Score to check the likelihood of Novo Nordisk's management manipulating its earnings.